Relationship Between Heart Failure With Preserved Ejection Fraction and Nonalcoholic Fatty Liver Disease.
1 other identifier
observational
100
1 country
2
Brief Summary
The aim of our study to determine the demography, relation between patients with heart failure with preserved ejection fraction and those with nonalcoholic fatty liver disease in Sohag university hospital.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2023
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 26, 2023
CompletedFirst Posted
Study publicly available on registry
April 21, 2023
CompletedStudy Start
First participant enrolled
April 29, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2023
CompletedApril 21, 2023
April 1, 2023
2 months
March 26, 2023
April 7, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
collection of results of echocardiography (those detect HFpEF) with abdominal ultrasound and transient elastography results (those detect NAFLD) and find relationship between the results.
looking for relationship between echocardiographic findings (that detect heart failure with preserved ejection fraction) and finding in abdominal ultrasound and transient elastography (detection of nonalcoholic fatty liver disease) to detect the relationship between those two diseases.
up to 28 weeks.
Study Arms (2)
HFpEF(heart failure with preserved ejection fraction)
chronic heart failure with echocardiographic finding of LVEF (left ventricular ejection fraction) equal or more than 50% , diagnostic test :Abdominal ultrasound and transient elastography for detecting non alcoholic fatty liver disease .
NAFLD(non alcoholic fatty liver disease)
ultrasound and transient elastographic finding of fatty liver disease, diagnostic test :echocardiography to determine heart failure with preserved ejection fraction .
Interventions
to determine finding of heart failure with preserved ejection fraction and non alcoholic fatty liver disease
Eligibility Criteria
all patients presented by heart failure with preserved ejection fraction and those with fatty liver disease
You may qualify if:
- clinical diagnosis of nonalcoholic fatty liver disease. -
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sohag Universitylead
Study Sites (2)
Asmaa elsayed khalifa
Sohag, El Monshah, 82515, Egypt
Asmaa E khalifa
Sohag, 82515, Egypt
Related Publications (1)
Savarese G, Lund LH. Global Public Health Burden of Heart Failure. Card Fail Rev. 2017 Apr;3(1):7-11. doi: 10.15420/cfr.2016:25:2.
PMID: 28785469RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Aml K Ahmed, A professor
Sohag University
- STUDY CHAIR
Alshimaa L Hamed, lecturer
Sohag University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 5 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- resident of internal medicine
Study Record Dates
First Submitted
March 26, 2023
First Posted
April 21, 2023
Study Start
April 29, 2023
Primary Completion
July 1, 2023
Study Completion
August 30, 2023
Last Updated
April 21, 2023
Record last verified: 2023-04